Nanocurcumin improved glucose metabolism in streptozotocin-induced diabetic rats: a comparison study with Gliclazide
- 28 April 2020
- journal article
- research article
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 27 (20) , 25271-25277
Abstract
In the present study, the biochemical effect of nanocurcumin (nanoCUR) compared with Gliclazide (GLZ) on the diabetic rats was studied. Forty male albino rats (Sprague Dawley) weighted 110 ± 20 g were used. Rats were randomly separated into two groups. Control, received no treatment. Streptozotocin (STZ)-induced diabetic groups take 5 ml/kg of STZ in normal saline daily for 30 days, further divided into diabetic non-treated group, did not receive any treatment: diabetic group treated by nanoCUR, received 15 mg/kg/day of nanoCUR orally for 30 days; diabetic group treated by GLZ, received 2 mg/kg/day of GLZ for 30 days. The mean body weights of all rats were registered and serum samples were collected for determination of fasting blood glucose (FBG), insulin concentration, liver glucokinase (GK), and glycogen synthase (GS) activities. Liver tissues were collected for determination of mRNA expression of insulin (INS), insulin receptor A (IRA), glucokinase (GK), and glucose transporter 2 (GLUT2). The results revealed a significant reduction of body weight in diabetic rats, with no significant differences in nanoCUR and GLZ groups. There was a decline in FBG levels and significant elevation of INS levels, GK, and GS activities in diabetic rats received nanoCUR and GLZ. mRNA expression of INS, IRA, GK, and GLUT2 significantly upregulated in diabetic rats received nanoCUR and GLZ. The amazing observation was a non-significant difference in all measured parameters between nanoCUR and GLZ groups. In conclusion, nanoCUR is able to improve cellular uptake of glucose, the hepatic insulin signaling, and insulin sensitivity in diabetic rats. Its effect was similar to standard hypoglycemic drug (GLZ).Keywords
Funding Information
- Board of College and University Development, Savitribai Phule Pune University (UJ-22-18-DR)
This publication has 51 references indexed in Scilit:
- Curcumin as potential therapeutic natural product: a nanobiotechnological perspectiveJournal of Pharmacy and Pharmacology, 2016
- Introducing Dendrosomal Nanocurcumin as a Compound Capable of in vitro Eliminating Undifferentiated Stem Cells in Cell Therapy PracticesExperimental and Clinical Endocrinology & Diabetes, 2015
- Phospho-BAD BH3 Mimicry Protects β Cells and Restores Functional β Cell Mass in DiabetesCell Reports, 2015
- Live imaging of GLUT2 glucose-dependent trafficking and its inhibition in polarized epithelial cystsOpen Biology, 2014
- Antidiabetic Activity of Zinc Oxide and Silver Nanoparticles on Streptozotocin-Induced Diabetic RatsInternational Journal of Molecular Sciences, 2014
- Efficacy of Biodegradable Curcumin Nanoparticles in Delaying Cataract in Diabetic Rat ModelPLOS ONE, 2013
- Regulation of glycogen synthase from mammalian skeletal muscle – a unifying view of allosteric and covalent regulationThe FEBS Journal, 2012
- Curcuminoids exert glucose‐lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double‐blind, placebo‐controlled trialMolecular Nutrition & Food Research, 2012
- Measurement of Glycogen Synthesis and Glycogen Synthase Activity in 3T3-L1 Adipocytes2002
- Hexokinase of Escherichia coli. Assay of Enzyme Activity and Adaptation to Growth in Various MediaJournal of General Microbiology, 1965